Reimagining India’s Pharmaceutical Sector: From Global Supplier to Innovation Leader
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
It performs white blood cell differential counts and quantifies red blood cell and platelet morphology,
The Toumai platform, currently the only robotic system with US FDA Study Approval for telesurgery, enabled real-time surgical control with no compromise to patient safety
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Shonan iPark was chosen for its globally connected life-science ecosystem, which unites pharmaceutical firms, next-generation medicine developers, AI and digital health innovators, venture capital, and academia
UK headquartered digital health scale-up strengthens global tech and innovation footprint in the country
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
Subscribe To Our Newsletter & Stay Updated